Cargando…
非小细胞肺癌的驱动基因及其临床意义
With the development of molecular biology technology and the transforming patterns of drug research, guiding molecular targeted therapy according to the drive gene mutation spectrum in lung cancer has gradually become a reality. Definition of the mutation incidence and whether existing advantage pop...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000100/ https://www.ncbi.nlm.nih.gov/pubmed/24949689 http://dx.doi.org/10.3779/j.issn.1009-3419.2014.06.08 |
| _version_ | 1783331617966653440 |
|---|---|
| collection | PubMed |
| description | With the development of molecular biology technology and the transforming patterns of drug research, guiding molecular targeted therapy according to the drive gene mutation spectrum in lung cancer has gradually become a reality. Definition of the mutation incidence and whether existing advantage population groups in non-small cell lung cancer (NSCLC) have important guiding significance in clinical practice. The purpose of this paper will draw a summary on the general characteristics, demographic features and clinical significance of driver genes in NSCLC. |
| format | Online Article Text |
| id | pubmed-6000100 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | 中国肺癌杂志编辑部 |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-60001002018-07-06 非小细胞肺癌的驱动基因及其临床意义 Zhongguo Fei Ai Za Zhi 综述 With the development of molecular biology technology and the transforming patterns of drug research, guiding molecular targeted therapy according to the drive gene mutation spectrum in lung cancer has gradually become a reality. Definition of the mutation incidence and whether existing advantage population groups in non-small cell lung cancer (NSCLC) have important guiding significance in clinical practice. The purpose of this paper will draw a summary on the general characteristics, demographic features and clinical significance of driver genes in NSCLC. 中国肺癌杂志编辑部 2014-06-20 /pmc/articles/PMC6000100/ /pubmed/24949689 http://dx.doi.org/10.3779/j.issn.1009-3419.2014.06.08 Text en 版权所有©《中国肺癌杂志》编辑部2014 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/ |
| spellingShingle | 综述 非小细胞肺癌的驱动基因及其临床意义 |
| title | 非小细胞肺癌的驱动基因及其临床意义 |
| title_full | 非小细胞肺癌的驱动基因及其临床意义 |
| title_fullStr | 非小细胞肺癌的驱动基因及其临床意义 |
| title_full_unstemmed | 非小细胞肺癌的驱动基因及其临床意义 |
| title_short | 非小细胞肺癌的驱动基因及其临床意义 |
| title_sort | 非小细胞肺癌的驱动基因及其临床意义 |
| topic | 综述 |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000100/ https://www.ncbi.nlm.nih.gov/pubmed/24949689 http://dx.doi.org/10.3779/j.issn.1009-3419.2014.06.08 |
| work_keys_str_mv | AT fēixiǎoxìbāofèiáideqūdòngjīyīnjíqílínchuángyìyì AT fēixiǎoxìbāofèiáideqūdòngjīyīnjíqílínchuángyìyì |